JW (Cayman) Therapeutics Co. Ltd
JW (Cayman) Therapeutics Co. Ltd (JWCTF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · JWCTF · as of Jun 9, 2026
Key Statistics
Explore JW (Cayman) Therapeutics Co. Ltd Data
jwctf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
jwctf competitorsJWCTF
BRIBF
BXPHF
GNFTF
IPHYF
MLLCFStock Performance
Full HistoryAbout JW (Cayman) Therapeutics Co. Ltd
JW (Cayman) Therapeutics Co. Ltd is a biopharmaceutical entity currently in the clinical development phase, dedicated to the discovery, manufacturing, and commercialization of advanced cell-based immu…
what is jw (cayman) therapeutics co. ltd · jwctf stock overview · jw (cayman) therapeutics co. ltd company profile · who is jw (cayman) therapeutics co. ltd ceo · jwctf OTC · jw (cayman) therapeutics co. ltd headquarters · jw (cayman) therapeutics co. ltd business segments
About Stock Overview & Key Data
JW (Cayman) Therapeutics Co. Ltd (JWCTF) is a Healthcare company in the Biotechnology industry, listed on OTC since Jul 15, 2021. As of the latest trading session, JWCTF stock price is $0.36, with a market capitalization of $147.9M. The stock has returned +42.04% over the past 12 months and -1.36% year-to-date.
In fiscal year 2025, JW (Cayman) Therapeutics Co. Ltd reported revenue of $276.3M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, JW (Cayman) Therapeutics Co. Ltd (JWCTF) stock price is $0.36. The stock is traded on OTC under the ticker symbol JWCTF. The 52-week range is $0.24 – $0.66.